Human Osteopontin (OPN) Quantikine ELISA Kit
| Name | Human Osteopontin (OPN) Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DOST00 |
| Category | ELISA Kit |
| Prices | $479.00, $2,290.00, $15,560.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Urine (50 uL), Human Milk (50 uL) |
| Sensitivity | 0.024 ng/mL |
| Range | 0.3 - 20 ng/mL (Cell Culture Supernates, EDTA Plasma, Heparin Plasma, Urine, Human Milk) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Osteopontin Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human Osteopontin in cell culture supernates, plasma, urine, and human milk |
| Gene | SPP1 |
| Supplier Page | Shop |
Product images
Product References
Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance - Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance
Shen ZH, Zeng DF, Wang XY, Ma YY, Zhang X, Kong PY. Oncol Lett. 2016 Nov;12(5):3278-3284. Epub 2016 Aug 24.
Development of an in vitro human liver system for interrogating nonalcoholic - Development of an in vitro human liver system for interrogating nonalcoholic
Feaver RE, Cole BK, Lawson MJ, Hoang SA, Marukian S, Blackman BR, Figler RA, Sanyal AJ, Wamhoff BR, Dash A. JCI Insight. 2016 Dec 8;1(20):e90954.
Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent - Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent
Arffa ML, Zapf MA, Kothari AN, Chang V, Gupta GN, Ding X, Al-Gayyar MM, Syn W, Elsherbiny NM, Kuo PC, Mi Z. PLoS One. 2016 Dec 9;11(12):e0167435.
Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy - Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy
Melve GK, Ersvaer E, Akkok CA, Ahmed AB, Kristoffersen EK, Hervig T, Bruserud O. Int J Mol Sci. 2016 Jul 19;17(7). pii: E1158.
Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system - Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system
Yushi Q, Li Z, Von Roemeling CA, Doeppler H, Marlow LA, Kim BY, Radisky DC, Storz P, Copland JA, Tun HW. Oncotarget. 2016 May 31;7(22):32156-71.
IL-6 trans-signaling is another pathway to upregulate Osteopontin. - IL-6 trans-signaling is another pathway to upregulate Osteopontin.
Uchibori T, Matsuda K, Shimodaira T, Sugano M, Uehara T, Honda T. Cytokine. 2017 Feb;90:88-95.
Biomarkers of inflammation and axonal degeneration/damage in patients with newly - Biomarkers of inflammation and axonal degeneration/damage in patients with newly
Stilund M, Gjelstrup MC, Petersen T, Moller HJ, Rasmussen PV, Christensen T. PLoS One. 2015 Apr 10;10(4):e0119681.
Prediction of cardiovascular events in statin-treated stable coronary patients of - Prediction of cardiovascular events in statin-treated stable coronary patients of
Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. PLoS One. 2014 Dec 22;9(12):e114519.
Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck - Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck
Aderhold C, Grobschmidt GM, Sauter A, Faber A, Hormann K, Schultz JD. Oncol Lett. 2014 Sep;8(3):1112-1118. Epub 2014 Jul 4.
Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with - Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with
Zhang H, Liu HB, Yuan DM, Wang ZF, Wang YF, Song Y. BMC Cancer. 2014 Apr 23;14:280.